Targeted DNA RNA Sequencing Market Size, Trends & Growth Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Targeted DNA RNA Sequencing Market Size Analysis

Global Targeted DNA RNA Sequencing Market Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value

North America Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value
U.S.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. NGS
    1. By Value
    2. Method
      1. Method By Value
    3. Exome Sequencing
      1. Exome Sequencing By Value
    4. Enrichment Sequencing
      1. Enrichment Sequencing By Value
    5. Amplicon Sequencing
      1. Amplicon Sequencing By Value
    6. Others
      1. Others By Value
  3. Application
    1. By Value
    2. Cancer Gene Sequencing
      1. Cancer Gene Sequencing By Value
    3. Inherited Disease Screening
      1. Inherited Disease Screening By Value
    4. Drug Development
      1. Drug Development By Value
    5. Forensic Genomics
      1. Forensic Genomics By Value
    6. 16S ribosomal RNA (rRNA) sequencing
      1. 16S ribosomal RNA (rRNA) sequencing By Value
  4. Others
    1. By Value
2. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Human Biomedical Research
    1. By Value
  3. Plant & Animal Sciences
    1. By Value
  4. Drug Discovery
    1. By Value
  5. Others
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. DNA-Based Targeted Sequencing
    1. By Value
  3. RNA-Based Targeted Sequencing
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic Research
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharma & Biotech Entities
    1. By Value
  5. Other Users
    1. By Value
Canada

Europe Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value
U.K.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. NGS
    1. By Value
    2. Method
      1. Method By Value
    3. Exome Sequencing
      1. Exome Sequencing By Value
    4. Enrichment Sequencing
      1. Enrichment Sequencing By Value
    5. Amplicon Sequencing
      1. Amplicon Sequencing By Value
    6. Others
      1. Others By Value
  3. Application
    1. By Value
    2. Cancer Gene Sequencing
      1. Cancer Gene Sequencing By Value
    3. Inherited Disease Screening
      1. Inherited Disease Screening By Value
    4. Drug Development
      1. Drug Development By Value
    5. Forensic Genomics
      1. Forensic Genomics By Value
    6. 16S ribosomal RNA (rRNA) sequencing
      1. 16S ribosomal RNA (rRNA) sequencing By Value
  4. Others
    1. By Value
2. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Human Biomedical Research
    1. By Value
  3. Plant & Animal Sciences
    1. By Value
  4. Drug Discovery
    1. By Value
  5. Others
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. DNA-Based Targeted Sequencing
    1. By Value
  3. RNA-Based Targeted Sequencing
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic Research
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharma & Biotech Entities
    1. By Value
  5. Other Users
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value
China
1. By Technology
  1. Introduction
    1. Technology By Value
  2. NGS
    1. By Value
    2. Method
      1. Method By Value
    3. Exome Sequencing
      1. Exome Sequencing By Value
    4. Enrichment Sequencing
      1. Enrichment Sequencing By Value
    5. Amplicon Sequencing
      1. Amplicon Sequencing By Value
    6. Others
      1. Others By Value
  3. Application
    1. By Value
    2. Cancer Gene Sequencing
      1. Cancer Gene Sequencing By Value
    3. Inherited Disease Screening
      1. Inherited Disease Screening By Value
    4. Drug Development
      1. Drug Development By Value
    5. Forensic Genomics
      1. Forensic Genomics By Value
    6. 16S ribosomal RNA (rRNA) sequencing
      1. 16S ribosomal RNA (rRNA) sequencing By Value
  4. Others
    1. By Value
2. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Human Biomedical Research
    1. By Value
  3. Plant & Animal Sciences
    1. By Value
  4. Drug Discovery
    1. By Value
  5. Others
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. DNA-Based Targeted Sequencing
    1. By Value
  3. RNA-Based Targeted Sequencing
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic Research
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharma & Biotech Entities
    1. By Value
  5. Other Users
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value
UAE
1. By Technology
  1. Introduction
    1. Technology By Value
  2. NGS
    1. By Value
    2. Method
      1. Method By Value
    3. Exome Sequencing
      1. Exome Sequencing By Value
    4. Enrichment Sequencing
      1. Enrichment Sequencing By Value
    5. Amplicon Sequencing
      1. Amplicon Sequencing By Value
    6. Others
      1. Others By Value
  3. Application
    1. By Value
    2. Cancer Gene Sequencing
      1. Cancer Gene Sequencing By Value
    3. Inherited Disease Screening
      1. Inherited Disease Screening By Value
    4. Drug Development
      1. Drug Development By Value
    5. Forensic Genomics
      1. Forensic Genomics By Value
    6. 16S ribosomal RNA (rRNA) sequencing
      1. 16S ribosomal RNA (rRNA) sequencing By Value
  4. Others
    1. By Value
2. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Human Biomedical Research
    1. By Value
  3. Plant & Animal Sciences
    1. By Value
  4. Drug Discovery
    1. By Value
  5. Others
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. DNA-Based Targeted Sequencing
    1. By Value
  3. RNA-Based Targeted Sequencing
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic Research
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharma & Biotech Entities
    1. By Value
  5. Other Users
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. NGS
  1. By Value
  2. Method
    1. Method By Value
  3. Exome Sequencing
    1. Exome Sequencing By Value
  4. Enrichment Sequencing
    1. Enrichment Sequencing By Value
  5. Amplicon Sequencing
    1. Amplicon Sequencing By Value
  6. Others
    1. Others By Value
3. Application
  1. By Value
  2. Cancer Gene Sequencing
    1. Cancer Gene Sequencing By Value
  3. Inherited Disease Screening
    1. Inherited Disease Screening By Value
  4. Drug Development
    1. Drug Development By Value
  5. Forensic Genomics
    1. Forensic Genomics By Value
  6. 16S ribosomal RNA (rRNA) sequencing
    1. 16S ribosomal RNA (rRNA) sequencing By Value
4. Others
  1. By Value
By Workflow
1. Introduction
  1. Workflow By Value
2. Pre-sequencing
  1. By Value
3. Sequencing
  1. By Value
4. Data Analysis
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Human Biomedical Research
  1. By Value
3. Plant & Animal Sciences
  1. By Value
4. Drug Discovery
  1. By Value
5. Others
  1. By Value
By Type
1. Introduction
  1. Type By Value
2. DNA-Based Targeted Sequencing
  1. By Value
3. RNA-Based Targeted Sequencing
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Academic Research
  1. By Value
3. Hospitals & Clinics
  1. By Value
4. Pharma & Biotech Entities
  1. By Value
5. Other Users
  1. By Value
Brazil
1. By Technology
  1. Introduction
    1. Technology By Value
  2. NGS
    1. By Value
    2. Method
      1. Method By Value
    3. Exome Sequencing
      1. Exome Sequencing By Value
    4. Enrichment Sequencing
      1. Enrichment Sequencing By Value
    5. Amplicon Sequencing
      1. Amplicon Sequencing By Value
    6. Others
      1. Others By Value
  3. Application
    1. By Value
    2. Cancer Gene Sequencing
      1. Cancer Gene Sequencing By Value
    3. Inherited Disease Screening
      1. Inherited Disease Screening By Value
    4. Drug Development
      1. Drug Development By Value
    5. Forensic Genomics
      1. Forensic Genomics By Value
    6. 16S ribosomal RNA (rRNA) sequencing
      1. 16S ribosomal RNA (rRNA) sequencing By Value
  4. Others
    1. By Value
2. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Pre-sequencing
    1. By Value
  3. Sequencing
    1. By Value
  4. Data Analysis
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Human Biomedical Research
    1. By Value
  3. Plant & Animal Sciences
    1. By Value
  4. Drug Discovery
    1. By Value
  5. Others
    1. By Value
4. By Type
  1. Introduction
    1. Type By Value
  2. DNA-Based Targeted Sequencing
    1. By Value
  3. RNA-Based Targeted Sequencing
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Academic Research
    1. By Value
  3. Hospitals & Clinics
    1. By Value
  4. Pharma & Biotech Entities
    1. By Value
  5. Other Users
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Targeted DNA RNA Sequencing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Illumina, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fisher Scientific Inc.
QIAGEN
Agilent Technologies, Inc.
Hoffmann-La Roche Ltd
BGI
PacBio
Oxford Nanopore Technologies plc.
Twist Bioscience
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
Takara Bio Inc.
PierianDx
Azenta Lifesciences
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment